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TO THE EDITOR
We thank Horn et al. (2012) for
mentioning the Genetic Alliance, the
Pseudoxanthoma Elasticum Inter-
national Registry, and the National
Psoriasis Foundation and providing
Internet links to these registries in their
letter regarding our commentary
‘‘Significance of Patient Registries for
Dermatological Disorders’’ (de Souza
and Miller, 2012). Table 1 in our
commentary included a select number
of registries and was not meant to be an
exhaustive or all-inclusive list.
With regard to the comment from
Horn et al. (2012) that Table 1
erroneously lists industry funding for
the Hereditary Angioedema Association
(HAEA) registry, we listed the HAEA as
the sponsor of the HAEA registry and
noted that the HAEA receives funding
from the industry sponsors listed in
Table 1, as the HAEA lists these
sponsors on their registry’s webpage.
The Cystic Fibrosis (CF) Registry was
mentioned as a gold standard because,
as stated in the commentary, it has
enrolled a large percentage (88%) of
the estimated number of CF patients in
the United States. The data from the CF
Registry are easily accessible in annual
reports published by the CF Foundation.
It would be helpful if similar annual
reports for the registries listed in Table 1
are made publicly available by their
sponsors. This will facilitate the compar-
isons between the registries suggested
by Horn et al.
We thank Horn et al. (2012) at the
Genetic Alliance, the National Psoriasis
Foundation, and the Pachyonychia
Congenita Project for their valuable
contributions to patient advocacy and
registries for dermatological and other
disorders.
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TO THE EDITOR
Exposure of the human skin to acute
solar UV irradiation induces several
members of the matrix metalloprotei-
nase family (MMPs), which degrade
collagen fibrils and other components
of the dermal extracellular matrix (ECM)
(Fisher et al., 1996; Yaar and Gilchrest,
2007). Elevation of MMPs due to
chronic sun exposure can promote
accumulation of dermal ECM fragmen-
tation, which contributes to impaired
skin function and aged appearance of
chronically sun-exposed skin (Fisher
et al., 1997). Histological and ultra-
structural studies have revealed that
there are major alterations in dermal
ECM, most notably the accumulation
of amorphous elastin-containing mate-
rial in the upper dermis, and disorga-
nized collagen fibrils, which constitute
the bulk (90% dry weight) of skin
connective tissue.
Elevation of MMPs and consequent
dermal collagen fibril fragmentation fol-
lowing acute UV irradiation in human
skin is well characterized (Fisher et al.,
1996; Quan et al., 2009). However, the
expression of MMPs in clinically
photodamaged human skin and the role
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Fragmented ECM Alters Collagen Homeostasis
